What is driving the growth of the Glycated Haemoglobin Testing Market?
The glycated haemoglobin testing market is witnessing significant growth, driven by the rising prevalence of diabetes worldwide and the increasing adoption of advanced diagnostic technologies. Glycated haemoglobin (HbA1c) tests provide an accurate, long-term measure of blood glucose levels, reflecting average glucose over the past two to three months. With more than 500 million people currently living with diabetes globally, according to the International Diabetes Federation (IDF), demand for effective monitoring solutions is surging.
The market was valued at USD 651.57 million in 2024 and is projected to grow at a CAGR of 8.20%, reaching USD 1,432.96 million by 2034. This growth is supported by technological advancements, government health initiatives, and a shift toward point-of-care (POC) testing for quicker and more convenient diabetes management.
Glycated Haemoglobin Testing Market Size and Growth Analysis
The market expansion is strongly tied to the growing burden of diabetes and pre-diabetes conditions. The test is considered the “gold standard” for monitoring long-term glycemic control, making it a vital diagnostic tool across hospitals, clinics, and research institutions.
Key drivers include:
Rising prevalence of lifestyle-related diseases such as obesity and cardiovascular conditions.
Growing awareness about early detection and continuous monitoring of diabetes.
Increasing healthcare investments in emerging economies.
Development of advanced immunoassay and chromatography technologies for precise results.
Segmentation of the Glycated Haemoglobin Testing Market
By Product Type
Laboratory HbA1c Testing Products – Widely adopted in hospitals and diagnostic centers due to their accuracy and large sample-handling capacity.
Point-of-Care (POC) HbA1c Testing Products – Rapidly gaining popularity for their portability and convenience, especially in primary healthcare and rural settings.
By Technology
Chromatography – Considered highly reliable, particularly HPLC (high-performance liquid chromatography), which remains a benchmark.
Immunoassay – Growing rapidly due to cost-effectiveness and ease of integration in diagnostic labs.
Others – Includes enzymatic and boronate affinity technologies, offering alternative testing mechanisms.
By End Use
Hospitals – The largest segment, supported by high patient inflow and reliance on comprehensive laboratory testing.
Diagnostic Centers – Increasingly investing in advanced HbA1c analyzers to meet rising demand.
Physical Examination Institutions – Growth driven by routine health checkups and preventive healthcare initiatives.
Research Institutions – Expanding applications in clinical research and drug development.
Others – Including home-based care and small clinics.
By Region
North America – Dominates the global market due to high diabetes prevalence, advanced healthcare infrastructure, and strong regulatory support.
Europe – Holds a substantial share, led by awareness programs and government health initiatives.
Asia Pacific – Expected to register the fastest growth, driven by rising diabetes cases in India and China, growing medical tourism, and adoption of POC testing.
Latin America – Growing due to increased healthcare access and investment in diagnostic technologies.
Middle East and Africa – Showing steady adoption, supported by improving healthcare infrastructure and awareness campaigns.
Competitive Landscape of the Glycated Haemoglobin Testing Market
The market is moderately consolidated, with key players focusing on innovation, product launches, and global expansion. Companies are also investing in AI-powered diagnostic solutions and partnerships with healthcare providers to strengthen their market presence.
Key Companies Covered
Abbott Laboratories – Offers advanced POC testing solutions with wide global reach.
Siemens AG – Provides laboratory-based HbA1c analyzers with strong accuracy.
Danaher Corp. – Focuses on chromatography-based diagnostic devices.
Bio-Rad Laboratories, Inc. – Known for high-performance laboratory testing solutions.
Beckman Coulter, Inc. – Expanding product portfolio in diagnostic testing.
Randox Laboratories Ltd. – Investing in innovative testing technologies.
Arkray, Inc. – Strong presence in diabetes monitoring solutions.
Others – Emerging players focusing on cost-effective HbA1c testing in developing regions.
Market Trends and Opportunities
Shift toward POC Testing: Faster results and portability are making POC HbA1c testing devices popular in both developed and emerging markets.
Integration with Digital Health: Growing use of connected devices and mobile apps for real-time diabetes management.
Expansion in Emerging Economies: Increasing government health spending and awareness campaigns in Asia Pacific and Africa.
Research Expansion: HbA1c testing is being explored beyond diabetes management, including cardiovascular and metabolic research.
Future Outlook of the Glycated Haemoglobin Testing Market
The market outlook remains highly positive, with demand set to double over the next decade. Technological innovation, adoption of digital diagnostic platforms, and increasing awareness about preventive healthcare are expected to further drive the market. By 2034, point-of-care testing and portable diagnostic devices will likely dominate, ensuring accessibility in both urban and rural settings.
Explore More Reports
Electronic Health Records (EHR) Market
Implantable Medical Devices Market
Allergic Rhinitis Epidemiology Forecast
About Us:
Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others.
Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.
Media Contact:
Company Name: Claight Corporation
Contact Person: Roshan Kumar, Digital Marketing
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
